SUMMARY Lineage mapping has identified both proliferative and quiescent intestinal stem cells, but the molecular circuitry controlling stem cell quiescence is incompletely understood. By lineage mapping, we show Lrig1, a pan-ErbB inhibitor, marks predominately non-cycling, long-lived stem cells located at the crypt base that, upon injury, proliferate and divide to replenish damaged crypts. Transcriptome profiling of Lrig1+ colonic stem cells differs markedly from highly proliferative, Lgr5+ colonic stem cells; genes up-regulated in the Lrig1+ population include those involved in cell cycle repression and response to oxidative damage. Loss of Apc in Lrig1+ cells leads to intestinal adenomas and genetic ablation of Lrig1 results in heightened ErbB1-3 expression and duodenal adenomas. These results shed light on the relationship between proliferative and quiescent intestinal stem cells, and support a model in which intestinal stem cell quiescence is maintained by calibrated ErbB signaling with loss of a negative regulator predisposing to neoplasia.

Cancer-associated fibroblasts (CAFs) in the tumor stroma play a key role in tumor progression. Erdogan et al. show that CAF-mediated alignment of the fibronectin matrix is a key factor promoting directional cancer cell migration.

Epithelial metaplasia occurs when one predominant cell type in a tissue is replaced by another, and is frequently associated with an increased risk of subsequent neoplasia. In both mouse and human pancreas, acinar-to-ductal metaplasia has been implicated in the generation of cancer precursors. We show that pancreatic epithelial explants undergo spontaneous acinar-to-ductal metaplasia in response to EGFR signaling, and that this change in epithelial character is associated with the appearance of nestin-positive transitional cells. Lineage tracing involving Cre/lox-mediated genetic cell labeling reveals that acinar-to-ductal metaplasia represents a true transdifferentiation event, mediated by initial dedifferentiation of mature exocrine cells to generate a population of nestin-positive precursors, similar to those observed during early pancreatic development. These results demonstrate that a latent precursor potential resides within mature exocrine cells, and that this potential is regulated by EGF receptor signaling. In addition, these observations provide a novel example of rigorously documented transdifferentiation within mature mammalian epithelium, and suggest that plasticity of mature cell types may play a role in the generation of neoplastic precursors.

The C1/RIPE3b1 (؊118/؊107 bp) binding factor regulates pancreatic-␤-cell-specific and glucose-regulated transcription of the insulin gene. In the present study, the C1/RIPE3b1 activator from mouse ␤TC-3 cell nuclear extracts was purified by DNA affinity chromatography and two-dimensional gel electrophoresis. C1/RIPE3b1 binding activity was found in the roughly 46-kDa fraction at pH 7.0 and pH 4.5, and each contained N-and C-terminal peptides to mouse MafA as determined by peptide mass mapping and tandem spectrometry. MafA was detected in the C1/RIPE3b1 binding complex by using MafA peptide-specific antisera. In addition, MafA was shown to bind within the enhancer region (؊340/؊91 bp) of the endogenous insulin gene in ␤TC-3 cells in the chromatin immunoprecipitation assay. These results strongly suggested that MafA was the ␤-cell-enriched component of the RIPE3b1 activator. However, reverse transcription-PCR analysis demonstrated that mouse islets express not only MafA but also other members of the large Maf family, specifically c-Maf and MafB. Furthermore, immunohistochemical studies revealed that at least MafA and MafB were present within the nuclei of islet ␤ cells and not within pancreas acinar cells. Because MafA, MafB, and c-Maf were each capable of specifically binding to and activating insulin C1 element-mediated expression, our results suggest that all of these factors play a role in islet ␤-cell function.Insulin is an essential regulator of metabolism. This hormone, which is synthesized by the ␤ cells of the islets of Langerhans, increases the storage of glucose, fatty acids, and amino acids through its actions in liver, adipose tissue, and muscle. Experiments performed in vivo with transgenic animals have established that the cis-acting elements controlling ␤-cell-selective expression are located within the insulin enhancer region, which is found between nucleotides Ϫ340 and Ϫ91 relative to the transcription start site. Several key control elements within the enhancer have been identified, including C2 (Ϫ317/ Ϫ311 bp), A3 (Ϫ201/Ϫ196 bp), C1 (Ϫ118/Ϫ107 bp), and E1 (Ϫ100/Ϫ91 bp) (37,60,67). Mutations that decrease the binding affinity of the A3, C1, and E1 activators also reduce glucose-regulated transcription (37,60,67).The activator of insulin C2-element stimulated transcription is Pax6 (61). Proteins in the Pax family all contain a paired box bipartite DNA-binding domain, although Pax6 also has a homeodomain. The Pdx-1 homeodomain protein (formerly known as IPF-1, STF-1, and IDX-1) is the regulator of A3 elementactivated expression (46,48,49,50), whereas the E1 activator is a heterodimer composed of proteins in the basic helix-loophelix family that are enriched in islets (i.e., BETA2 [42]) and generally distributed (i.e., HEB [51] and E2A [2,10,17,65]). In the adult pancreas, Pax6 (61) and BETA2 (42) are found in all islet cell types, whereas Pdx-1 appears to be found only in ␤ cells, a subset of islet ␦ cells (48,49), and exocrine acinar cells (71,80). These transcription factors are necessary for ma...

Insulin gene expression is regulated by several islet-enriched transcription factors. However, MafA is the only ␤ cell-specific activator. Here, we show that MafA selectively induces endogenous insulin transcription in non-␤ cells. MafA was also first detected in the insulin-producing cells formed during the second and predominant phase of ␤ cell differentiation, and absent in the few insulin-positive cells found in Nkx6.1 ؊/؊ pancreata, which lack the majority of second-phase ␤ cells. These results demonstrate that MafA is a potent insulin activator that is likely to function downstream of Nkx6.1 during islet insulin-producing cell development.

SummaryCre/LoxP-mediated DNA recombination allows for gene function and cell lineage analyses during embryonic development and tissue regeneration. Here, we describe the derivation of a K19 CreERT mouse line in which the tamoxifen-activable CreER T was knocked into the endogenous cytokeratin 19 locus. In the absence of tamoxifen, leaky Cre activity could be detected only in less than 1% of stomach and intestinal epithelial cells, but not in pancreatic or hepatic epithelial tissues. Tamoxifen administration in postnatal animals induced widespread DNA recombination in epithelial cells of pancreatic ducts, hepatic ducts, stomach, and intestine in a dose-dependent manner. Significantly, we found that Cre activity could be induced in the putative gut stem/ progenitor cells that sustained long-term gut epithelial expression of a Cre reporter. This mouse line should therefore provide a valuable reagent for manipulating gene activity and for cell lineage marking in multiorgans during normal tissue homeostasis and regeneration.Keywords lineage tracing; pancreas; small intestine; colon; liver; kidney; stomach; Cre The Cre/LoxP-based technology allows for functional analyses of essential genes in specific organs by gene inactivation or controlled ectopic gene expression (Branda and Dymecki, 2004;Lewandoski, 2001;Sauer and Henderson, 1988). When combined with detectable marker protein expression, Cre-LoxP allows for cell lineage analyses in living animals (Branda and Dymecki, 2004;Gu et al., 2003). Upon modifying Cre to produce a tamoxifen (TM)-dependent molecule, CreER T , it is now possible to control Cre activity both spatially and temporally (Metzger and Chambon, 2001). This feature allows for dissecting the genetic requirements for cell/tissue homeostasis and for following cell lineages during tissue regeneration.We have derived a K19 CreERT knockin allele to recombine DNA in epithelial cells of several adult organs. K19 encodes an intermediate filament protein (Moll et al., 1982) that is expressed in multiple cell types from the epiblast stage and is maintained in multiple epithelial cell types of later embryonic and postnatal stages (Bosch et al., 1988;Lane et al., 1983;Moll et al., 1982;Quinlan et al., 1985). For example, K19 is highly expressed in the pancreatic ducts of the adult pancreas (Deramaudt et al., 2006), but is absent or weak in acini and islets (Brembeck et al., 2001 We derived a K19 CreERT allele by replacing K19 ATG with a CreER T -cDNA followed by a SV40 polyadenylation signal (see Fig. 1). This design minimally altered K19 transcription regulatory elements while producing a CreER T message with a short 3′-UTR. Inclusion of a polyadenylation signal 3′ to the CreER T sequence prevented the transcription of the five noncoding exons of the endogenous K19 gene. Otherwise, the presence of these noncoding exons in CreER T mRNA could trigger nonsense-mediated mRNA degradation (Conti and Izaurralde, 2005;Doma and Parker, 2007). Thus, adding an extra polyadenylation signal immediately down-stream of CreER T c...

Background & Aims Mutational inactivation of APC is an early event in colorectal cancer (CRC) progression that affects the stability and increases the activity of β-catenin, a mediator of Wnt signaling. CRC progression also involves inactivation of signaling via transforming growth factor (TGF)β and bone morphenogenic protein (BMP), which are tumor suppressors. However, the interactions between these pathways are not clear. We investigated the effects of loss of the transcription factor Smad4 loss on levels of β-catenin mRNA and Wnt signaling. Methods We used microarray analysis to associate levels of Smad4 and β-catenin mRNA in colorectal tumor samples from 250 patients. We performed oligonucleotide-mediated knockdown of Smad4 in human embryonic kidney (HEK293T) and in HCT116 colon cancer cells and transgenically expressed Smad4 in SW480 colon cancer cells. We analyzed adenomas from (APCΔ1638/+) and (APCΔ1638/+)x(K19CreERT2Smad4lox/lox) mice using laser-capture microdissection. Results In human CRC samples, reduced levels of Smad4 correlated with increased levels of β-catenin mRNA. In Smad4-depleted cell lines, levels of β-catenin mRNA and Wnt signaling increased. Inhibition of BMP or depletion of Smad4 in HEK293T cells increased binding of RNA polymerase II to the β-catenin gene. Expression of Smad4 in SW480 cells reduced Wnt signaling and levels of β-catenin mRNA. In mice with heterozygous disruption of Apc(APCΔ1638/+), Smad4-deficient intestinal adenomas had increased levels of β-catenin mRNA and expression of Wnt target genes, compared with adenomas from APCΔ1638/+mice that expressed Smad4. Conclusions Transcription of β-catenin is inhibited by BMP signaling to Smad4. These findings provide important information about the interaction among TGF-β, BMP, and Wnt signaling pathways in CRC progression.

We have identified a sequence element that specifies the position of transcription initiation for the dihydrofolate reductase gene. Unlike the functionally analogous TATA box that directs RNA polymerase II to initiate transcription 30 nucleotides downstream, the positioning element of the dihydrofolate reductase promoter is located directly at the site of transcription initiation. By using DNase I footprint analysis, we have shown that a protein binds to this initiator element. Transcription initiated at the dihydrofolate reductase initiator element when 28 nucleotides were inserted between it and all other upstream sequences, or when it was placed on either side of the DNA helix, suggesting that there is no strict spatial requirement between the initiator and an upstream element. Although neither a single Spl-binding site nor a single initiator element was sufficient for transcriptional activity, the combination of one Spl-binding site and the dihydrofolate reductase initiator element cloned into a plasmid vector resulted in transcription starting at the initiator element. We have also shown that the simian virus 40 late major initiation site has striking sequence homology to the dihydrofolate reductase initiation site and that the same, or a similar, protein binds to both sites. Examination of the sequences at other RNA polymerase II initiation sites suggests that we have identified an element that is important in the transcription of other housekeeping genes. We have thus named the protein that binds to the initiator element HIP1 (Housekeeping Initiator Protein 1).Interactions between transcription factors and specific DNA sequences within an RNA polymerase II promoter can be grouped into two categories, depending upon how they influence transcription. One class of factors, usually binding at least 50 base pairs (bp) upstream of the initiation site, regulates the efficiency of transcription, presumably by altering the rate or conformation of polymerase attachment. Examples of this class of factors are Spl (6,26)